News: Auxilium Pharmaceuticals Inc (AUXL.OQ)
AUXL.OQ on NASDAQ Stock Exchange Global Select Market
19.65USD
1 Aug 2013
19.65USD
1 Aug 2013
Price Change (% chg)
$1.29 (+7.03%)
$1.29 (+7.03%)
Prev Close
$18.36
$18.36
Open
$19.58
$19.58
Day's High
$20.93
$20.93
Day's Low
$18.65
$18.65
Volume
788,685
788,685
Avg. Vol
203,044
203,044
52-wk High
$26.55
$26.55
52-wk Low
$13.88
$13.88
Select another date:
Mon, Apr 29 2013
Auxilium cuts sales outlook, expands urology business
- Auxilium Pharmaceuticals Inc reported a big drop in quarterly sales in the United States for both of its drugs, and said it acquired Actient Holdings LLC to bolster its urology business.
UPDATE 2-Auxilium cuts sales outlook, expands urology business
April 29 - Auxilium Pharmaceuticals Inc reported a big drop in quarterly sales in the United States for both of its drugs, and said it acquired Actient Holdings LLC to bolster its urology business.
Select another date:
- Auxilium Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript
- 5 Stocks Set to Soar on Bullish Earnings
- Are You Expecting This from Auxilium Pharmaceuticals?
- Huge Potential For First Line Therapy For Frozen Shoulder
- BioSpecifics Poised For Run Up Into Near-Term FDA Catalyst
- FDA Decisions: Interesting Biotechnology Catalyst Events
Press Releases
- Auxilium Pharmaceuticals Announces Encouraging Top-line 30-Day Data from XIAFLEX® (CCH) Phase Ib Study in Cellulite
- Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
- Analyst Opinion on Perrigo Co. and Auxilium Pharmaceuticals Inc. - Drug Related Product Companies Remain Healthy
- NuPathe Announces Third Quarter 2012 Financial Results and Operational Highlights
- Auxilium and Pfizer Will Conclude Agreement on XIAPEX® EU Collaboration
- Auxilium Pharmaceuticals, Inc. Submits Supplemental Biologics License Application to the FDA for XIAFLEX® for the Treatment of Peyronie's Disease
- Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
- Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
- A Little Homework Goes a Long Way - Research & Analysis on Perrigo Company and Auxilium Pharmaceuticals, Inc.
- Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX® Safety Update

